Pnc Financial Services Group, Inc. Teva Pharmaceutical Industries LTD Transaction History

Pnc Financial Services Group, Inc.

  • $156 Billion
  • Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 59,255 shares of TEVA stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,255
Previous 62,005 4.44%
Holding current value
$1.04 Million
Previous $1.01 Million 5.96%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$15.81 - $18.96 $43,477 - $52,140
-2,750 Reduced 4.44%
59,255 $1.07 Million
Q2 2024

Aug 09, 2024
SELL
$12.78 - $17.4 $76,999 - $104,834
-6,025 Reduced 8.86%
62,005 $1.01 Million
Q1 2024

May 10, 2024
BUY
$10.67 - $14.43 $36,950 - $49,971
3,463 Added 5.36%
68,030 $959,000
Q4 2023

Feb 09, 2024
SELL
$8.12 - $10.63 $51,894 - $67,936
-6,391 Reduced 9.01%
64,567 $674,000
Q3 2023

Nov 13, 2023
BUY
$7.48 - $10.7 $6,672 - $9,544
892 Added 1.27%
70,958 $723,000
Q2 2023

Aug 11, 2023
SELL
$7.2 - $9.47 $59,832 - $78,695
-8,310 Reduced 10.6%
70,066 $527,000
Q1 2023

May 15, 2023
BUY
$8.36 - $11.37 $25,255 - $34,348
3,021 Added 4.01%
78,376 $693,000
Q4 2022

Feb 10, 2023
BUY
$7.95 - $9.48 $10,064 - $12,001
1,266 Added 1.71%
75,355 $687,000
Q3 2022

Nov 10, 2022
SELL
$6.86 - $11.95 $71,302 - $124,208
-10,394 Reduced 12.3%
74,089 $597,000
Q2 2022

Aug 12, 2022
SELL
$7.38 - $10.4 $255,296 - $359,767
-34,593 Reduced 29.05%
84,483 $635,000
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $95,795 - $122,717
13,069 Added 12.33%
119,076 $1.12 Million
Q4 2021

Feb 11, 2022
SELL
$7.9 - $10.19 $11,518 - $14,857
-1,458 Reduced 1.36%
106,007 $849,000
Q3 2021

Nov 05, 2021
SELL
$8.38 - $10.18 $139,501 - $169,466
-16,647 Reduced 13.41%
107,465 $1.05 Million
Q2 2021

Aug 06, 2021
SELL
$9.9 - $11.56 $47,638 - $55,626
-4,812 Reduced 3.73%
124,112 $1.23 Million
Q1 2021

May 07, 2021
BUY
$10.34 - $12.81 $202,405 - $250,755
19,575 Added 17.9%
128,924 $1.49 Million
Q4 2020

Feb 12, 2021
SELL
$8.61 - $11.04 $42,214 - $54,129
-4,903 Reduced 4.29%
109,349 $1.06 Million
Q3 2020

Nov 06, 2020
SELL
$8.57 - $12.69 $33,962 - $50,290
-3,963 Reduced 3.35%
114,252 $1.03 Million
Q2 2020

Aug 07, 2020
SELL
$8.12 - $13.12 $49,458 - $79,913
-6,091 Reduced 4.9%
118,215 $1.46 Million
Q1 2020

May 08, 2020
SELL
$6.69 - $13.45 $25,709 - $51,688
-3,843 Reduced 3.0%
124,306 $1.12 Million
Q4 2019

Feb 07, 2020
SELL
$6.53 - $10.72 $26,531 - $43,555
-4,063 Reduced 3.07%
128,149 $1.26 Million
Q3 2019

Nov 08, 2019
BUY
$6.16 - $9.6 $53,746 - $83,760
8,725 Added 7.07%
132,212 $909,000
Q2 2019

Aug 09, 2019
SELL
$8.12 - $15.72 $268,674 - $520,143
-33,088 Reduced 21.13%
123,487 $0
Q1 2019

May 10, 2019
SELL
$15.58 - $20.01 $10,812 - $13,886
-694 Reduced 0.44%
156,575 $0
Q4 2018

Feb 08, 2019
SELL
$14.59 - $23.84 $374,058 - $611,209
-25,638 Reduced 14.02%
157,269 $2.43 Million
Q3 2018

Nov 09, 2018
SELL
$21.06 - $25.65 $100,603 - $122,530
-4,777 Reduced 2.55%
182,907 $0
Q2 2018

Aug 10, 2018
SELL
$16.77 - $24.71 $428,825 - $631,859
-25,571 Reduced 11.99%
187,684 $0
Q1 2018

May 11, 2018
SELL
$16.68 - $22.07 $644,164 - $852,321
-38,619 Reduced 15.33%
213,255 $0
Q4 2017

Feb 09, 2018
SELL
$11.23 - $19.1 $1.33 Million - $2.27 Million
-118,805 Reduced 32.05%
251,874 $0
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $5.71 Million - $11.9 Million
370,679
370,679 $0

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email